EN DE

Pulmuone Corporate (017810) Fair Value & Analysis

Consumer Defensive · KR · Market cap 324B KRW

PC Pulmuone Corporate 017810 · KO
Price9,430 KRW
Fair Value10,300 KRW
Upside+9.2%
Quality50/100
Watch Pulmuone Corporate for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 0.8% net margin
Moderate debt · generates free cash flow
1.16% dividend yield
Trails peers (3/10)
Narrow moat 29/100
Evidence: Medium Range 7,725 KRW – 12,875 KRW Share as image

Fair value as of: Jul 22, 2026

From 25 valuation models · updated 19 days ago

Share price +2.8% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Our model range runs from 7,725 KRW (bear) to 12,875 KRW (bull), base 10,300 KRW. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 50/100 (solid quality) with medium evidence: read the verdict with care.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

22,104 KRW 8,610 KRW Fair Value 10,300 KRW Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range 8,610 KRW – 22,104 KRW · fair‑value band 7,725 KRW – 12,875 KRW · the 9,430 KRW price screens below the 10,300 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Pulmuone Corporate (017810) currently trades at 9,430 KRW, while our model-based Fair Value estimate is 10,300 KRW, implying the stock looks roughly 9.2% fairly valued today. The Quality Score stands at 50/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Pulmuone Corporate generated revenue of 3.4T KRW at a net margin of 0.8%. Revenue grew 7.2% year over year. It earns a return on equity of 4.1%. Net debt stands at 674B KRW. Fundamentals as of Jul 22, 2026

Our scenario range runs from 7,725 KRW (bear case) to 12,875 KRW (bull case); at 9,430 KRW, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 49% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 9%, 017810 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 1,097 KRW 3,201 KRW 6,761 KRW 80
Residual Income 6,770 KRW 7,064 KRW 7,268 KRW 76
ROIC Compounder 21,812 KRW 29,391 KRW 38,967 KRW 72
All 25 models by family
DCF Models
FCF DCF 1,055 KRW 3,157 KRW 6,660 KRW 38
Owner Earnings 9,916 KRW 17,964 KRW 31,376 KRW 31
5Y Revenue Exit 13,902 KRW 27,930 KRW 46,640 KRW 39
5Y EBITDA Exit 41,500 KRW 81,147 KRW 129,341 KRW 41
5Y P/E Exit 3,636 KRW 8,135 KRW 13,022 KRW 38
10Y Revenue Exit 8,748 KRW 20,788 KRW 38,411 KRW 36
10Y EBITDA Exit 27,721 KRW 59,219 KRW 104,859 KRW 37
10Y P/E Exit 2,732 KRW 6,493 KRW 11,400 KRW 35
Earnings-Based
Graham-Dodd 3,335 KRW 11,922 KRW 16,060 KRW 54
Lynch FV 2,808 KRW 4,012 KRW 5,216 KRW 50
PEG = 1.0 2,808 KRW 4,012 KRW 5,216 KRW 46
EPV 19,598 KRW 23,423 KRW 26,823 KRW 59
Dividend Discount
Gordon GGM 6,129 KRW 13,381 KRW 22,514 KRW 70
DDM Multi-Stage 6,129 KRW 10,961 KRW 13,945 KRW 61
Multiples
P/E Multiple 7,725 KRW 10,300 KRW 12,875 KRW 63
P/S Multiple 6,253 KRW 8,338 KRW 10,422 KRW 58
P/B Multiple 6,253 KRW 8,338 KRW 10,422 KRW 55
EV/EBIT 30,122 KRW 40,855 KRW 51,588 KRW 53
EV/EBITDA 67,976 KRW 91,328 KRW 114,679 KRW 54
EV/Revenue 20,904 KRW 30,753 KRW 40,603 KRW 43
Asset-Based
NCAV (Graham) 4,203 KRW 5,632 KRW 8,405 KRW 50
Growth DCF
Growth DCF 1,097 KRW 3,201 KRW 6,761 KRW 80
Economic Profit
Residual Income 6,770 KRW 7,064 KRW 7,268 KRW 76
ROIC Compounder 21,812 KRW 29,391 KRW 38,967 KRW 72
Growth Earnings
Growth-Adj P/E 5,378 KRW 7,682 KRW 9,987 KRW 68

Widest divergence: DCF Models (17,964 KRW) versus Growth DCF (3,201 KRW). Highest evidence: Growth DCF (80).

Notify me when 017810 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 3.4T KRW
Revenue growth (YoY) +7.2%
Net margin 0.8%
Return on equity 4.1%
Free cash flow 9.3B KRW FY2025
Operating margin 2.2%
More key figures
Dividend yield 1.2%
EPS growth (YoY) -92.1%
Net debt 674B KRW FY2025

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 50/100

Of which business quality 47 · Market factors (momentum, volatility) 27

Profitability 47
Margins and returns on capital today
Quality Growth 49
Are margins and returns improving?
Cashflow 36
Earnings quality: real cash, not paper profit
Fin. Strength 12
Balance sheet, leverage, solvency risk
Investment 88
Disciplined investing over empire-building
Low Volatility 70
Calm price path (market factor)
Momentum 10
Price trend over the last 3–12 months (market factor)
52W Momentum 8
Distance to the 52-week high (market factor)
Net Issuance 81
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Pulmuone Corporate manufactures, sells, and distributes foods and beverages in South Korea, the United States, China, and Japan. The company provides functional foods, mineral water, and fermented milk products, as well as meal, concession, and catering services; and distributes whole foods. It also offers health and living solutions.

Full company description

Pulmuone Corporate manufactures, sells, and distributes foods and beverages in South Korea, the United States, China, and Japan. The company provides functional foods, mineral water, and fermented milk products, as well as meal, concession, and catering services; and distributes whole foods. It also offers health and living solutions. Pulmuone Corporate was founded in 1981 and is headquartered in Eumseong-eup, South Korea.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Pulmuone Corporate reported revenue of 3.4T KRW in FY2025 versus 2.5T KRW in FY2021, a compound +7.6%/yr. Reported net income was 18.1B KRW in FY2025, compounding +7.9%/yr from FY2021.

Growth Quality 62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
3.4T KRW
Latest YoY
+5.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.0%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.9%
Avg. growth/yr (25Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+11.7%
Revenue +7.6%/yr
FY21 2.5T KRW
FY22 2.8T KRW
FY23 3.0T KRW
FY24 3.2T KRW
FY25 3.4T KRW
Net income +7.9%/yr
FY21 13.4B KRW
FY22 −18.6B KRW
FY23 19.5B KRW
FY24 35.4B KRW
FY25 18.1B KRW

Watch 017810: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Pulmuone Corporate Fair Value". https://www.fairvalue-calculator.com/stock/017810

Peer Group

Packaged Foods · 649 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 50 · Below median
Fair Value upside +9% · Above median
Return on equity (TTM) 4% · Below median
Return on assets 3% · Below median
Net margin (TTM) 1% · Below median
Operating margin (TTM) 2% · Below median
Revenue growth 7% · Above median
Dividend yield (TTM) 1.2% · Below median
Debt / equity 0.67× · Higher than 75% of peers

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 46 · sector 28
FUTURE 36 · sector 20
PAST 16 · sector 27
HEALTH 67 · sector 96
DIVIDEND 23 · sector 47

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,427 ₹362.37 -75%
Britannia Industries Limited BRITANNIA ₹5,413 ₹1,870 -65%
Tata Consumer Products Limited TATACONSUM ₹1,089 ₹327.27 -70%
PT Indofood CBP Sukses Makmur Tbk ICBP 6,650 IDR 15,757 IDR +137%
Samyang Foods Co 003230 1,139,000 KRW 1,010,543 KRW -11%
Patanjali Foods Limited PATANJALI ₹413.80 ₹157.04 -62%
Vietnam Dairy Products Joint Stock Company VNM 58,500 VND 68,259 VND +17%
PT Mayora Indah Tbk, MYOR 1,750 IDR 2,699 IDR +54%
PT Cisarua Mountain Dairy Tbk CMRY 4,490 IDR 4,355 IDR -3%
Nongshim Co 004370 348,500 KRW 530,619 KRW +52%

Compare Pulmuone Corporate with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Pulmuone Corporate (017810) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of 10,300 KRW versus a price of 9,430 KRW, about +9% (fairly valued).
What is the fair value of 017810?
Our model-based fair value for Pulmuone Corporate is 10,300 KRW (as of Jul 22, 2026), built from audited fundamentals. The current price is 9,430 KRW.
What is the quality score of 017810?
Pulmuone Corporate has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Pulmuone Corporate (017810)?
Pulmuone Corporate reported trailing-twelve-month revenue of about 3.4T KRW (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 017810?
The net profit margin of Pulmuone Corporate is about 0.8%, meaning it keeps roughly 0.8% of revenue as net income. Based on the latest reported figures.
Does Pulmuone Corporate pay a dividend?
Pulmuone Corporate currently shows a dividend yield of about 1.04% relative to its recent price (as of Jul 22, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Pulmuone Corporate and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.